cc-220
Showing 1 - 14 of 14
Lymphoma, B-Cell Trial in Worldwide (CC-220, Rituximab, Cyclophosphamide)
Recruiting
- Lymphoma, B-Cell
- CC-220
- +6 more
-
Scottsdale, Arizona
- +26 more
Jul 1, 2022
Lymphoma Trial in Worldwide (CC-220, Rituximab, Obinutuzumab)
Recruiting
- Lymphoma
- CC-220
- +2 more
-
Phoenix, Arizona
- +36 more
Jul 28, 2022
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- JCAR017
- +7 more
-
Duarte, California
- +17 more
Jan 13, 2023
Lymphoma, B-Cell Trial in Worldwide (CC-220, Polatuzumab vedotin, Rituximab)
Withdrawn
- Lymphoma, B-Cell
- CC-220
- +8 more
-
Boston, Massachusetts
- +26 more
Sep 28, 2021
Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)
Recruiting
- Multiple Myeloma
- CC-220
- +4 more
-
Scottsdale, Arizona
- +126 more
Jan 10, 2023
Hepatic Impairment, Healthy Volunteers Trial in Miami, Orlando, San Antonio (CC-220)
Completed
- Hepatic Impairment
- Healthy Volunteers
- CC-220
-
Miami, Florida
- +2 more
Jul 23, 2020
Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)
Recruiting
- Multiple Myeloma
- BB2121
- +2 more
-
Birmingham, Alabama
- +33 more
Jan 26, 2023
Healthy Trial in Madison (CC-220 0.03 mg, CC-220 0.1 mg, CC-220 0.3 mg)
Completed
- Healthy
- CC-220 0.03 mg
- +6 more
-
Madison, WisconsinCovance Clinical Research Unit
Nov 7, 2019
Lupus Erythematosus, Systemic Trial in Worldwide (CC-220, Placebo)
Completed
- Lupus Erythematosus, Systemic
- CC-220
- Placebo
-
Tuscaloosa, Alabama
- +115 more
Sep 1, 2021
Systemic Lupus Erythematosus Trial in United States (CC-220, Placebo)
Completed
- Systemic Lupus Erythematosus
- CC-220
- Placebo
-
Birmingham, Alabama
- +34 more
Mar 5, 2020
Healthy Volunteer Trial in Madison (CC-220, [14C])
Completed
- Healthy Volunteer
- CC-220
- [14C]
-
Madison, WisconsinCovance Clinical Research Unit
Oct 24, 2017
Healthy Volunteers Trial in Overland Park (CC-220)
Completed
- Healthy Volunteers
- CC-220
-
Overland Park, KansasQuintiles Phase One Services, LLC
Jun 30, 2017
Pharmacokinetics Trial in Austin (CC-220, Rifampin, Itraconazole)
Completed
- Pharmacokinetics
- CC-220
- +2 more
-
Austin, TexasPPD Development, LP
Oct 17, 2016
Healthy Volunteers Trial in Madison (CC-220, Placebo)
Completed
- Healthy Volunteers
- CC-220
- Placebo
-
Madison, WisconsinCovance Clinical Research Unit
Jan 10, 2014